Combination devices to protect women from sexual transmission of HIV

Drug Delivery Technology

Volumn 9, Issue 3, 2009, Pages 18-

  Gokhale, Abhijit ^a   McConnell, Jason ^a   Loxley, Andrew ^a   Mitchnick, Mark ^a  

^a Particle Sciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CELLACEFATE; DAPIVIRINE; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHYLENE VINYL ACETATE COPOLYMER; ETONOGESTREL; MICROBICIDE; PROGERING; PROGESTERONE; UNCLASSIFIED DRUG;

ARTICLE; CONTRACEPTION; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; HERPES SIMPLEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROENCAPSULATION; PHYSICAL CHEMISTRY; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; SILICONE PROSTHESIS; VAGINA RING; VIRUS INHIBITION; WOMEN'S HEALTH;

EID: 65349146629     PISSN: 15372898     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (11)

1. Macht DI. The absorption of drugs and poisons through the vagina. J Pharmacol Pathol. 1918;10:509-522.
2. Sitruk-Ware R. Delivery options for contraceptives. Drug Discovery Today 2005;10:977-985.
3. Johnson T, Frey R, Modugno M, Brennan T, Margulies B. Development of an acyclovir implant for the effective long-term control of herpes simplex virus type-1 infection in Vero cells and in experimentally infected SKH-1 mice. Int J Antimicrobial Agents. 2007;30:428-435.
4. Sweet RL. New approaches for the treatment of bacterial vaginosis. Am J Obstet Gynecol. 1993;169:479-482.
5. Das Neves J, Bahia MF. Gels as vaginal drug delivery systems. Int J Pharmaceutics. 2006;318:1-14.
6. Malcolm K, McCullough S, Woolfson D, Catney M, Tallon P. A dynamic mechanical method for determining the silicone elastomer solubility of drugs and pharmaceutical excipients in silicone intravaginal drug delivery rings. Biomaterials. 2002;23:3589-3594.
7. Malcolm K, Woolfson D, Russell J, Tallon P, McAuley L, Craig D. Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings. J Controlled Release. 2003;90:217-225.
8. Malcolm K, Woolfson D, Russell J, Tallon P, McAuley L, Craig D. Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings. J Controlled Release. 2006;90:217-225.
9. Ahrendt H, Nisand I, Bastianelli C, Gomez M, Gemzell-Danielsson K, Urdl W, Karskov B, Oeyen L, Bitzer J, Page G, Milsom I. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 micrograms of ethinyl estradiol and 3 mg of drospirenone. Contraception. 2006;74:451-457.
10. Croxatto HB, Makarainen L. The pharmacodynamics and efficacy of Implanon: an overview of the data. Contraception. 1998;58:915-975.
11. Lim J, Wolitz R, Dowling A, Bloom H, Irvine A, Schwartz D. Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis. Ganciclovir Implant Complications. 1998;127:288-293.